Evidence map›Paper›PMID 35187501›Full record

ArticleNature aging2021

Evidence for accelerated aging in mammary epithelia of women carrying germline

Sundus F Shalabi, Masaru Miyano, Rosalyn W Sayaman, Jennifer C Lopez, Tiina A Jokela, Michael E Todhunter, Stefan Hinz, James C Garbe, Martha R Stampfer, Kai Kessenbrock and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nature aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Signaling pathways and targeted interventions for precancers.Signal transduction and targeted therapy · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
  14. Article
  15. CD105Breast cancer research : BCR · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity.Advances in experimental medicine and biology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Sundus F ShalabiDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.ORCID http://orcid.org/0000-0002-8440-2474
Masaru MiyanoDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Rosalyn W SayamanDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Jennifer C LopezDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Tiina A JokelaDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Michael E TodhunterDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Stefan HinzDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
James C GarbeBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-4041-3868
Martha R StampferBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Kai KessenbrockBiological Chemistry Department, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-0410-6104
Victoria E SeewaldtDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA. vseewaldt@coh.org.ORCID http://orcid.org/0000-0002-7289-9268
Mark A LaBargeDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA. mlabarge@coh.org.ORCID http://orcid.org/0000-0003-2405-4719
City of Hope · USLawrence Berkeley National Laboratory · USAl-Quds University · PSUniversity of California, Irvine · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Project 2U54CA285116 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Victoria L. Seewaldt · 2023 to 2026
$6.8M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
Mechanical Phenotyping of Random Periaerolar Fine Needle Aspiration-Collected Cells for Early Breast Cancer DetectionR01EB024989 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI Mark A LaBarge, Lydia L Sohn · 2017 to 2026
$4.8M
Microenvironmental regulation of breast tumorigenesisR01CA234496 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kai Kessenbrock · 2019 to 2026
$4.3M
Diversity Supplement to Combined Breast MRI/Biomarker Strategies to Identify Aggressive BiologyU01CA189283 · NCI · DUKE UNIVERSITY · PI CLINTON, STEVEN K, MIRANDA-CARBONI, GUSTAVO ADOLFO · 2015 to 2020
$4.0M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
Tension-Stat3-miR-mediated metastasisR01CA192914 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SEEWALDT, VICTORIA L., WEAVER, VALERIE MARIE · 2015 to 2019
$2.9M
Involution-based biomarkers of breast cancer riskR01CA237602 · NCI · MAYO CLINIC JACKSONVILLE · PI DEGNIM, AMY C, RADISKY, DEREK C · 2020 to 2024
$2.8M
Mechanisms of breast cancer associated with obesityR01CA170851 · NCI · TUFTS UNIVERSITY BOSTON · PI KUPERWASSER, CHARLOTTE, SEEWALDT, VICTORIA L. · 2012 to 2015
$2.6M
Cancer Metabolism Training ProgramT32CA221709 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI David K. Ann, Victoria L. Seewaldt · 2018 to 2026
$1.8M
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (Pilot Project 2)P20CA242620 · NCI · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MARTINEZ, ERNEST · 2019 to 2022
$1.2M
NCI NIH HHS P20 CA242619NCI NIH HHS P20 CA242620NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA170851NCI NIH HHS R01 CA192914NCI NIH HHS R01 CA234496NCI NIH HHS R01 CA237602NCI NIH HHS T32 CA221709NCI NIH HHS U01 CA189283NCI NIH HHS U01 CA244109NCI NIH HHS U54 CA285116NIA NIH HHS R33 AG059206NIBIB NIH HHS R01 EB024989
6 · The paper itself

Abstract

During aging in the human mammary gland, luminal epithelial cells lose lineage fidelity by expressing markers normally expressed in myoepithelial cells. We hypothesize that loss of lineage fidelity is a general manifestation of epithelia that are susceptible to cancer initiation. In the present study, we show that histologically normal breast tissue from younger women who are susceptible to breast cancer, as a result of harboring a germline mutation in

Indexed as

Breast NeoplasmsMammary Glands, HumanAgingBRCA1 ProteinBRCA2 ProteinBreastFemaleGerm-Line MutationHumansBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID35187501
PMCPMC8849557
OpenAlexW3201460397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.